BerandaOCEAW • NASDAQ
add
Ocean Biomedical
Tutup sebelumnya
$0,028
Rentang hari
$0,019 - $0,032
Rentang tahun
$0,015 - $0,18
Kapitalisasi pasar
1,41 jt USD
Volume Rata-Rata
43,29 rb
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 1,75 jt | 365,61% |
Laba bersih | 283,00 rb | 101,68% |
Margin laba bersih | — | — |
Penghasilan per saham | — | — |
EBITDA | — | — |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | — | — |
Total aset | 902,00 rb | -83,60% |
Total liabilitas | 98,52 jt | 2,34% |
Total ekuitas | -97,62 jt | — |
Saham yang beredar | 166,01 jt | — |
Harga terhadap nilai buku | -0,01 | — |
Tingkat pengembalian aset | -430,92% | — |
Tingkat pengembalian modal | 5,65% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 283,00 rb | 101,68% |
Kas dari operasi | -2,52 jt | -190,99% |
Kas dari investasi | — | — |
Kas dari pembiayaan | 2,50 jt | 198,45% |
Perubahan kas bersih | -16,00 rb | 40,74% |
Arus kas bebas | -4,49 jt | -247,31% |
Tentang
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Didirikan
2019
Kantor pusat
Situs
Karyawan
7
